133 related articles for article (PubMed ID: 38142871)
1. In vitro permeation of nicotine and tobacco specific nitrosamines from smokeless tobacco product extracts in a 3D buccal tissue model.
Keyser BM; Flockton H; Weidman RA; Payne R; Rowe J; Jordan KG
Toxicol Lett; 2024 Feb; 392():36-45. PubMed ID: 38142871
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity, oxidative stress, and inflammatory response of smokeless tobacco extracts and cytotoxicity of combustible cigarette whole smoke in a 3D oral organotypic buccal cell model.
Keyser BM
Toxicol Mech Methods; 2022 Jun; 32(5):352-361. PubMed ID: 34923904
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity of Nicotiana gossei leaves, used in the Australian Aboriginal smokeless tobacco known as pituri or mingkulpa.
Moghbel N; Ryu B; Cabot PJ; Ratsch A; Steadman KJ
Toxicol Lett; 2016 Jul; 254():45-51. PubMed ID: 27178269
[TBL] [Abstract][Full Text] [Related]
4. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).
Back S; Masser AE; Rutqvist LE; Lindholm J
BMC Chem; 2023 Mar; 17(1):9. PubMed ID: 36869349
[TBL] [Abstract][Full Text] [Related]
5. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
Richter P; Hodge K; Stanfill S; Zhang L; Watson C
Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
[TBL] [Abstract][Full Text] [Related]
7. An in Vitro Study of Constituents Released from Smokeless Tobacco Products into Human Saliva.
Guan S; Bush L; Ji H
J Anal Toxicol; 2022 Jul; 46(6):625-632. PubMed ID: 34155520
[TBL] [Abstract][Full Text] [Related]
8. The Swedish snus and the Sudanese toombak: are they different?
Idris AM; Ibrahim SO; Vasstrand EN; Johannessen AC; Lillehaug JR; Magnusson B; Wallström M; Hirsch JM; Nilsen R
Oral Oncol; 1998 Nov; 34(6):558-66. PubMed ID: 9930371
[TBL] [Abstract][Full Text] [Related]
9. Chemical characterization of domestic oral tobacco products: total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines.
Lawler TS; Stanfill SB; Zhang L; Ashley DL; Watson CH
Food Chem Toxicol; 2013 Jul; 57():380-6. PubMed ID: 23517910
[TBL] [Abstract][Full Text] [Related]
10. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.
Hoffmann D; Djordjevic MV; Fan J; Zang E; Glynn T; Connolly GN
J Natl Cancer Inst; 1995 Dec; 87(24):1862-9. PubMed ID: 7494230
[TBL] [Abstract][Full Text] [Related]
11. Method development and validation of dissolution testing for nicotine release from smokeless tobacco products using flow-through cell apparatus and UPLC-PDA.
Miller JH; Danielson T; Pithawalla YB; Brown AP; Wilkinson C; Wagner K; Aldeek F
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122012. PubMed ID: 32065955
[TBL] [Abstract][Full Text] [Related]
12. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
13. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
Andersson G; Björnberg G; Curvall M
J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
[TBL] [Abstract][Full Text] [Related]
14. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
Stepanov I; Biener L; Yershova K; Nyman AL; Bliss R; Parascandola M; Hatsukami DK
Nicotine Tob Res; 2014 Aug; 16(8):1070-8. PubMed ID: 24604020
[TBL] [Abstract][Full Text] [Related]
15. Potential Application of USP Paddle and Basket Dissolution Methods in Discriminating for Portioned Moist Snuff and Snus Smokeless Tobacco Products.
Rahman Z; Dharani S; Khuroo T; Khan MA
AAPS PharmSciTech; 2021 Jan; 22(1):51. PubMed ID: 33459904
[TBL] [Abstract][Full Text] [Related]
16. Smokeless Tobacco Products (STPs) Harbour Bacterial Populations with Potential for Oral Carcinogenicity.
Monika S; Dineshkumar T; Priyadharini S; Niveditha T; Sk P; Rajkumar K
Asian Pac J Cancer Prev; 2020 Mar; 21(3):815-824. PubMed ID: 32212812
[TBL] [Abstract][Full Text] [Related]
17. High-Intensity Sweeteners in Alternative Tobacco Products.
Miao S; Beach ES; Sommer TJ; Zimmerman JB; Jordt SE
Nicotine Tob Res; 2016 Nov; 18(11):2169-2173. PubMed ID: 27217475
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive chemical characterization of Rapé tobacco products: Nicotine, un-ionized nicotine, tobacco-specific N'-nitrosamines, polycyclic aromatic hydrocarbons, and flavor constituents.
Stanfill SB; Oliveira da Silva AL; Lisko JG; Lawler TS; Kuklenyik P; Tyx RE; Peuchen EH; Richter P; Watson CH
Food Chem Toxicol; 2015 Aug; 82():50-8. PubMed ID: 25934468
[TBL] [Abstract][Full Text] [Related]
19. A novel model mouth system for evaluation of In Vitro release of nicotine from moist snuff.
Li P; Zhang J; Sun SH; Xie JP; Zong YL
Chem Cent J; 2013 Nov; 7(1):176. PubMed ID: 24215662
[TBL] [Abstract][Full Text] [Related]
20. Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches.
Mallock N; Schulz T; Malke S; Dreiack N; Laux P; Luch A
Tob Control; 2024 Feb; 33(2):193-199. PubMed ID: 38378209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]